Prevention of perioperative acute renal failure: What works?

Best Practice and Research: Clinical Anaesthesiology

Volumn 18, Issue 1, 2004, Pages 91-111

  Tang, Ignatius Y ^a   Murray, Patrick T ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acetylcysteine; Acute renal failure; Diuretics; Nephrotoxins; Perioperative; Vasodilators

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; AMINOGLYCOSIDE; AMINOPHYLLINE; AMPHOTERICIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CALCINEURIN INHIBITOR; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; DOPEXAMINE; FENOLDOPAM; HYPERTENSIVE FACTOR; INOTROPIC AGENT; IODINATED CONTRAST MEDIUM; MANNITOL; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PROSTAGLANDIN; RADIOISOTOPE; SOMATOMEDIN C; THEOPHYLLINE; UNINDEXED DRUG; URODILATIN; VASOACTIVE AGENT; VASODILATOR AGENT; DRUG;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE EXACERBATION; FLUID THERAPY; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART SURGERY; HEMODIALYSIS; HUMAN; INCIDENCE; INTESTINE ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE FUNCTION; MAJOR SURGERY; MORBIDITY; MORTALITY; NEPHROTOXICITY; NONHUMAN; OFF PUMP CORONARY SURGERY; PATHOGENESIS; PATIENT MONITORING; PERFUSION PRESSURE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; TACHYCARDIA; UREMIA; VASCULAR SURGERY; CHEMICALLY INDUCED DISORDER; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION;

HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY FAILURE, ACUTE; PERIOPERATIVE CARE; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT;

EID: 2142816609     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2003.09.006     Document Type: Review

References (124)

1. Carmichael P. Carmichael A.R. Acute renal failure in the surgical setting Australian and New Zealand Journal of Surgery 73 2003 144-153
2. Reddy V.G. Prevention of postoperative acute renal failure Journal of Postgraduate Medicine 48 2002 64-70
3. Swanninathana M. Stafford-Smith M. Renal dysfunction after vascular surgery Current Opinion in Anaesthesiology 16 2003 45-51
4. Conlon P. Stafford-Smith M. White W. et al. Acute renal failure following cardiac surgery Nephrology Dialysis and Transplantation 14 1999 1158-1162
5. Thakar C.V. Yared J.P. Worley S. et al. Renal dysfunction and serious infections after open heart surgery Kidney International 64 2003 239-246
6. Dimick J.B. Pronovost P.J. Cowan J.A. Lipsete P.A. Complications and costs after high risk surgery: where should we focus quality improvement initiatives? Journal of the American College of Surgery 196 2003 671-678
7. Mangano C.M. Diamondstone L.S. Ramsey J.G. et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of perioperative Ischemic Research Group Annals of Internal Medicine 128 1998 194-203
8. Chertow G.M. Lazarus M. Christiansen C.L. et al. Pre-operative renal risk stratification Circulation 95 1997 878-884
9. Asione R. Nason G. Al-Ruzzeh S. et al. Coronary revascularization with or without cardiopulmonary bypass in patients with pre-operative non-dilaysis-dependent renal insufficiency Annals of Thoracic Surgery 72 2001 2020-2025
10. Wahlberg E. DiMuzio P.J. Stoney R.J. Aortic clamping during elective operations for infrarenal disease: the influence of clamping time on renal function Journal of Vascular Surgery 36 2002 13-18
11. Citttanova M.L. Zubichi A. Savu C. et al. The chronic inhibition of angiotensin-converting enzyme impairs post-operative renal function Anesthesia and Analgesia 93 2001 1111-1115
12. Biancofiore G. Bindi M.L. Romanelli A.M. et al. Intraabdominal pressure monitoring in liver transplant recipients: a prospective study Intensive Care Medicine 29 2003 30-36
13. Ben-David B. Croitoru M. Gaitini L. Acute renal failure following laporoscopic cholecystectomy: a case report Journal of Clinical Anesthesia 11 1999 486-489
14. Albahran M.J. Swaminathan M. Phillips-Bute B. et al. Postcardiac surgery complications: association of acute renal dysfunction and atrial fibrillation Anesthesia and Analgesia 96 2003 637-643
15. Holte K. Sharrock N.E. Kehlet H. Pathophysiologic and clinical implications of peri-operative fluid excess British Journal of Anaesthesia 89 2002 22-32
16. Thadhani R. Pascual M. Bonventre J.V. Acute Renal Failure New England Journal of Medicine 334 1996 1448-1460
17. Kasiske B.L. Keane W.F. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy in: Brenner B.M. Brenner - Rector The Kidney sixth edn 2000 1129-1164 W.B. Saunders Philadelphia
18. Hsu C.-Y. Chertow G.M. Curhan G.C. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency Kidney International 61 2002 1567-1576
19. Cockroft D.W. Gault M.H. Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31-41
20. Levey A.S. Bosch J.P. Breyer Lewis J. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Annals of Internal Medicine 30 1999 461-470
21. Murray P.T. Pathogenesis and management of septic shock Seminars in Anesthesia, Perioperative Medicine, and Pain 18 1999 192-203
22. Murray P.T. Wylam M.E. Umans J.G. Nitric oxide and septic vascular dysfunction Anesthesia and Analgesia 90 2000 89-101
23. Ragaller M.J.R. Theilen H. Koch T. Volume replacement in critically ill patients with acute renal failure Journal of the American Society of Nephrology 12 2001 S33-S39
24. Boldt J. Brenner T. Lehmann A. et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin Intensive Care Medicine 29 2003 763-769
25. Sinclair S. James S. Singer M. Intraoperative intravenous volume optimization and length of stay after repair of proximal femoral fracture: a randomized controlled trial British Medical Journal 315 1997 909-909
26. Venn R. Steele A. Richardson P. et al. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and peri-operative morbidity in patients with hip fractures British Journal of Anaesthesia 88 2002 65-71
27. Connolly S.J. Cybulsky I. Lamy A. et al. Double-blind placebo-controlled randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta blocker length of stay (BLOS) study American Heart Journal 145 2003 226-232
28. Mangro D.T. Layug E.L. Wallace A. Tates I. for the Multicenter study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery New England Journal of Medicine 335 1996 1713-1720
29. Howell S.J. Sear W. Foex P. Peri-operative beta-blockade: a useful treatment that should be greeted with cautious enthusiasm British Journal of Anaesthesia 86 2001 161-164
30. Wagner F. Yeter R. Bisson S. et al. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction Critical Care Medicine 31 2003 1421-1428
31. Wilson J. Woods J. Fawcett J. et al. Reducing the risk of major elective surgery: randomized controlled trial of pre-operative optimization of oxygen delivery British Medical Journal 318 1999 1099-1103
32. Bersten A.D. Holt A.W. Vasoactive drugs and the importance of renal perfusion pressure New Horizons 3 1995 650-661
33. Kelleher S.P. Robinette J.B. Conger J.D. Sympathetic nervous system in the loss of autoregulation in acute renal failure American Journal of Physiology 246 1984 F379-F386
34. Mackay J.H. Feerick A.E. Woodson L.C. et al. Increasing organ blood flow during cardiopulmonary bypass in pigs: comparison of dopamine and perfusion pressure Critical Care Medicine 23 1995 1090-1098
35. O'Dwyer C. Woodson L.C. Conroy B.P. Regional perfusion abnormalities with phenylephrine during normothermic bypass Annals of Thoracic Surgery 63 1997 728-735
36. Urzua J. Tronscoso S. Bugedo G. et al. Renal function and cardiopulmonary bypass: effect of perfusion pressure Journal of Cardiothoracic and Vascular Anesthesia 6 1992 299-303
37. Andersson L.G. Bratteby L.E. Ekroth R. et al. Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure European Journal of Cardiothoracic Surgery 8 1994 597-602
38. Morales D.L. Garrido M.J. Madigan J.D. et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass Annals of Thoracic Surgery 75 2003 926-930
39. Patel B.M. Chittock D.R. Russell J.A. Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock Anesthesiology 96 2003 576-582
40. Edwards R.M. Trizna W. Kinter L.B. Renal microvascular effects of vasopressin and vasopressin antagonists American Journal of Physiology 256 1989 F274-F278
41. Zager R.A. Endotoxemia, renal hypoperfusion, and fever: interactive risk factors for aminoglycoside and sepsis-induced acute renal failure American Journal of Kidney Disease 20 1992 223-230
42. Lameire N. Vanholder R. Pathophysiologic features and prevention of human and experimental ATN Journal of the American Society of Nephrology 12 2001 S20-S32
43. Dishart M.L. Kellum J.A. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure Drugs 59 2000 79-91
44. Garwood S. New pharmacologic options for renal preservation Anesthesiology Clinic of North America 18 2000 753-771
45. Bellomo R. Chapman M. Finfer S. et al. Low dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 356 2000 2139-2143
46. Kellum J.A. Decker J.M. Use of dopamine in acute renal failure: a meta-analysis Critical Care Medicine 29 2001 1526-1531
47. Marik P.E. Low dose dopamine: a systematic review Intensive Care Medicine 28 2002 877-883
48. Lassnigg A. Donner E. Grubhofer G. et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery Journal of the American Society of Nephrology 11 2000 97-104
49. Tang A.T. El-Gamel A. Keevil B. et al. The effect of renal dose dopamine on renal tubular function following cardiac surgery: assessed by measuring retinal binding protein (RBP) European Journal of Cardiovascular Surgery 15 1999 717-721
50. Chertow G.M. Sayegh M.H. Allgren R.L. Lazarus J.M. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group American Journal of Medicine 101 1996 49-53
51. Abizaid A.S. Clark C.E. Mintz G.S. et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency American Journal of Cardiology 83 1999 260-263
52. Neiberger R.E. Passmore J.C. Effects of dopamine on canine intrarenal blood flow distribution during hemorrhage Kidney International 15 1979 219-226
53. Murphy M.B. Murray C. Shorten G.D. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension New England Journal of Medicine 345 2001 1548-1557
54. Bodner A. Murray P. Fenoldopam: a dopaminergic vasodilator Current Concepts in Hypertension 4 2000 5-6
55. Brogden R.N. Fenoldopam M.A. A review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies Drugs 54 1997 634-650
56. Singer I. Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure American Journal of Kidney Disease 31 1998 743-755
57. Elliott W.J. Weber R.R. Nelson K.S. et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension Circulation 81 1990 970-977
58. Shusterman N.H. Elliott W.J. White W.B. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function American Journal of Medicine 95 1993 161-168
59. Aronson S. Goldberg L.I. Roth S. et al. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs Canadian Journal of Anesthesia 37 1990 380-384
60. Aronson S. Goldberg L.I. Roth S. et al. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia Journal of Cardiothoracic and Vascular Anesthesia 5 1991 29-32
61. Kien N.D. Moore P.G. Jaffe R.S. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs Anesthesia and Analgesia 74 1992 74-82
62. Mathur V.S. Swan S.K. Lambrecht L.J. et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects Critical Care Medicine 27 1999 1832-1837
63. Allison N.L. Dubb J.W. Ziemniak J.A. et al. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics Clinical Pharmacology and Therapeutics 41 1987 282-288
64. Poinsot O. Romand J.A. Favre H. Suter P.M. Fenoldopam improves renal hemodynamics impaired by positive pressure Anesthesiology 79 1993 680-684
65. Schuster H.P. Suter P.M. Hemmer M. et al. Fenoldopam improves renal dysfunction secondary to ventilation with PEEP Intensivmedizin 28 1991 348-355
66. Jorkasky D.K. Audet P. Shusterman N. et al. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients American Jouranl of Kidney Disease 19 1992 567-572
67. Bakris G.L. Lass N.A. Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors Kidney International 56 1999 206-210
68. Siragy H.M. Felder R.A. Howell N.L. et al. Evidence that dopamine-2 mechanisms control renal function American Journal of Physiology 259 1990 F793-F800
69. Carey R.M. Siragy H.M. Ragsdale N.V. Dopamine-1 and Dopamine-2 mechanisms in the control of renal function American Journal of Hypertension 3 1990 59S-63S
70. Germann R. Hasibeder W. Haisjackl M. et al. Dopamine-1-receptor stimulation and mucosal tissue oxygenation in the porcine jejunum Critical Care Medicine 23 1995 1560-1566
71. Vlavianos P. Polson R.J. Settin A. et al. Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis British Journal of Clinical Pharmacology 29 1990 19-25
72. Hadengue A. Moreau R. Bacq Y. et al. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic, and renal hemodynamic study Hepatology 13 1991 111-116
73. Patel J.J. Mitha A.S. Sareli P. de Vaal J.B. Intravenous fenoldopam infusion in severe heart failure Cardiovascular Drugs and Therapy 7 1993 97-101
74. Barnard M.L. Ridge K.M. Saldias F. et al. Stimulation of the dopamine 1 receptor increases lung edema clearance American Journal of Respiratory and Critical Care Medicine 160 1999 982-986
75. Heyman S.N. Brezis M. Epstein F.H. et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin Kidney International 40 1991 632-642
76. Weisberg L.S. Kurnik P.B. Kurnik B.R. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction Kidney International 41 1992 1408-1415
77. Liss P. Nygren A. Erikson U. Ulfendahl H.R. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla Kidney International 53 1998 698-702
78. Tumlin J.A. Wang A. Murray P.T. Mathur V.S. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy Amercan Heart Journal 143 2002 894-903
79. Stone G.W. Tumlin J.A. Madyoon H. et al. Design and rationale of CONTRAST-a prospective, randomized placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy Reviews in Cardiovascular Medicine 2 supplement 1 2001 S31-S35
80. Stone GW, McCullough PA, Tumlin JA, for the CONTRAST Investigators. Prospective, placebo-controlled evaluation of fenoldopam mesylate, a specific dopamine-1 receptor agonist, for the prevention of contrast-induced nephropathy. Presented at the American College of Cardiology Annual Meeting, Chicago; March 31st, 2003.
81. Halpenny M. Markos F. Snow H.M. et al. The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs European Journal of Anaesthesiology 17 2000 491-498
82. Halpenny M. Lakshmi S. O' Donnell A. et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting Anaesthesia 56 2001 953-960
83. Halpenny M. Rushe C. Breen P. et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery European Journal of Anesthesiology 19 2002 32-39
84. Sheinbaum R. Ignacio C. Safi H.J. Estrera A. Contemporary strategies to preserve renal function during cardiac and vascular surgery Reviews in Cardiovascular Medicine 4 supplement 1 2003 S21-S28
85. Halpenny M. Markos F. Snow H.M. et al. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs Critical Care Medicine 29 2001 855-860
86. Kellum J.A. Systematic review: the use of diuretics and dopamine in renal failure: a systemic review of the evidence Critical Care Medicine 1 1997 53-59
87. Shilliday I.R. Quinn K.J. Allison M.E.M. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled randomized study Nephrology Dialysis and Transplantation 12 1997 2592-2596
88. Solomon R. Werner C. Maun D. et al. Effects of saline, mannitol and furosemide to prevent acute decreases in renal function induced by radiocontrast agents New England Journal of Medicine 331 1994 1410-1420
89. Visweswaran P. Massin E.K. Dubose T.D.Jr. Mannitol-induced acute renal failure Journal of the American Society of Nephrology 8 1997 1028-1033
90. Allgren R.L. Marbury T.C. Rahman S.N. et al. Anaritide in acute tubular necrosis New England Journal of Medicine 336 1997 828-834
91. Forssmann W.G. Meyer M. Forssmann K. The renal urodilatin system: clinical implications Journal of Cardiovascular Research 51 2001 456-462
92. Hummel M. Kuhn M. Bub A. et al. Urodilatin: a new peptide with beneficial effects in the post-operative therapy of cardiac transplant recipients Clinical Investigation 70 1992 674-682
93. Brenner P. Meyer M. Reichenspurner H. et al. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplant European Journal of Medical Research 1 1995 137-143
94. Wagner K. Albredt S. Neumayer H.H. Prevention of post-transplant ATN by the calcium antagonist diltiazem: a prospective, randomized study American Journal of Nephrology 7 1987 287-291
95. Neumayer H.H. Kunzendorf U. Schreiber M. Protective effects of calcium antagonists in human renal transplantation Kidney International 36 supplement 1992 S87-S93
96. Piper S.N. Kumble B. Maleck W.H. et al. Diltiazem may preserve renal tubular integrity after cardiac surgery Canadian Journal of Anesthesia 503 2003 285-292
97. Amano J. Suzuki A. Sunamori M. Tofukuji M. Effect of calcium antagonist diltiazem on renal function in open heart surgery Chest 107 1995 1260-1265
98. Amar D. Fleisher M. Diltiazem treatment does not alter renal function after thoracic surgery Chest 119 2001 1476-1479
99. Young E. Diab A. Kirsh M.M. Intravenous diltiazem and acute renal failure after cardiac operation Annals of Thoracic Surgery 1998 1316-1319
100. Bergman A.S. Odar-Cederlof I. Westman L. et al. Diltiazem infusion for renal protection in cardiac surgical patients with pre-existing renal dysfunction Journal of Cardiothoracic and Vascular Anesthesia 16 2002 294-299
101. Kawamura T. Nara N. Kadosaki M. et al. PGE1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokine production during cardiac surgery Critical Care Medicine 28 2000 2201-2208
102. Manesia A.R. Leibowitz A.B. Miller C.M. et al. Post-operative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients Journal of the American College of Surgery 182 1996 347-352
103. Morgera S. Woydt R. Kern H. et al. Low-dose prostacyclin preserves renal function in high risk patients after coronary bypass surgery Critical Care Medicine 30 2002 107-112
104. Kramer B.K. Preuner J. Ebenburger A. et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery Nephrology Dialysis and Transplantation 17 2002 910-915
105. Pollak R. Andrisevic J.H. Maddux M.S. et al. A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation Transplantation 55 1993 57-60
106. Tepel M. van der Giet M. Schwarzfeld C. et al. Prevention of radiographic contrast agent induced reduction in renal function by acetylcysteine New England Journal of Medicine 343 2000 180-184
107. Shyu K.-G. Cheng J.-J. Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure Journal of the American College of Cardiology 40 2002 1383-1388
108. Buccamdro F. Amhad M. Smelling R.W. Sodringola S. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheterization and Cardiovascular Intervention 58 2003 336-341
109. Molnar Z. Szkany T. Koszegi T. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomized, double-blinded, placebo-controlled clinical trial Intensive Care Medicine 29 2003 749-755
110. Wijnem M.H.W.A. Raumen R.M.H. Vader H.L. et al A multioxidant supplementation reduces damage from ischemia reperfusion in patients after lower torso ischemia. A randomized trial European Journal of Vascular and Endovascular Surgery 23 2002 486-490
111. Boldt J. Brosch C. Piper S.N. et al. Influence of prophylactic use of pentoxyfylline on post-operative organ function in elderly cardiac surgery patients Critical Care Medicine 29 2001 952-958
112. Hirschberg R. Kopple J. Lipsett P. et al. Multicenter clinical trial of recombinant human insulin-like growth factor 1 in patients with acute renal failure Kidney International 55 1999 2423-2432
113. Franklin S.C. Moulton M. Sicaro G.A. Insulin-like growth factor-1 preserves renal function post-operatively American Journal of Physiology 272 1997 F257-F259
114. Durmcaz I. Yagdi T. Calkaur T. et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronmary artery bypass surgery Annals of Thoracic Surgery 75 2003 859-864
115. Kim K.B. Kang C.H. Chang W.I. et al. Off-pump coronary artery bypass with complete avoidance of aortic manipulation Annals of Thoracic Surgery 74 2002 S1377-S1382
116. Van Belleghem Y. Caci F. Maene L. et al. Off-pump coronary surgery: surgical strategy for the high risk patients Cardiovascular Surgery 11 2003 75-79
117. Carpenter J.P. Fairman R.M. Barker C.F. et al. Endovascular AAA repair inpatients with renal insufficiency: strategies for reducing adverse renal events Cardiovascular Surgery 9 2001 559-564
118. Bolke E. Jehle P.M. Storck M. et al. Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute response and clinical outcome Clinica Chimica Acta 314 2001 203-207
119. Fitridge R.A. Petrucoo M. Dunlop C.M. et al. Arteriography in chronic renal failure: a case for carbon dioxide Cardiovascular Surgery 7 1999 323-326
120. Aspelin P. Aubry P. Fransson S.G. et al. Nephrotoxic effects in high risk patients undergoing angiography New England Journal of Medicine 348 2003 491-499
121. Sam A.D. Morasch M.D. Collins J. Song G. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency Journal of Vascular Surgery 38 2003 313-318
122. Skusa M.D. A2A adenosine receptor: a novel target in renal disease American Journal of Physiology (Renal Physiology) 2 2002 F271-F282
123. Krause S.M. Walsh T.F. Greenlee W.J. et al. Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dog Journal of the American Society of Nephrology 8 1997 1061-1071
124. de Vries B. Matthijsen R.A. van Bijnen A.A. Wolfs T.G. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apotosis and complement activation American Journal of Pathology 63 2003 47-56